Target Name: MIR4746
NCBI ID: G100616371
Review Report on MIR4746 Target / Biomarker Content of Review Report on MIR4746 Target / Biomarker
MIR4746
Other Name(s): hsa-miR-4746-3p | hsa-miR-4746-5p | hsa-mir-4746 | mir-4746 | MicroRNA 4746 | microRNA 4746

MIR4746: A Drug Target / Disease Biomarker

MIR4746 is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the Mir gene family, which encodes for a family of transmembrane proteins that play important roles in various cellular processes. One of the most well-studied proteins in the Mir family is MIR4746, which is known for its role in the regulation of insulin sensitivity and glucose metabolism.

MIR4746 is expressed in the brain and has been shown to be involved in the development and progression of several neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It is also involved in the regulation of glucose metabolism and has been shown to play a role in the development of type 2 diabetes.

In addition to its potential involvement in neurological and metabolic disorders, MIR4746 is also a potential drug target. Several studies have identified MIR4746 as a potential drug target for the treatment of type 2 diabetes, and clinical trials are currently being conducted to evaluate the effectiveness of drugs that target this protein.

One of the reasons why MIR4746 is thought to be a promising drug target is its involvement in the regulation of insulin sensitivity and glucose metabolism. Insulin sensitivity is an important factor in the development of type 2 diabetes, and MIR4746 has been shown to play a role in regulating insulin sensitivity in various tissues.

Several studies have shown that MIR4746 is involved in the regulation of insulin sensitivity in muscle cells, fat cells, and pancreatic beta cells. These cells are important in the production of insulin, which is a hormone that helps regulate blood sugar levels. By regulating insulin sensitivity in these cells, MIR4746 may be able to contribute to the development of insulin resistance and the development of type 2 diabetes.

Another reason why MIR4746 is thought to be a promising drug target is its involvement in the regulation of neurodegenerative diseases. Several studies have shown that MIR4746 is involved in the regulation of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells and can be treated with drugs that target the expression of MIR4746.

In addition to its potential involvement in neurological and metabolic disorders, MIR4746 is also a potential drug target for the treatment of type 2 diabetes. Several studies have shown that MIR4746 is involved in the regulation of insulin sensitivity in various tissues, including muscle cells, fat cells, and pancreatic beta cells. These cells are important in the production of insulin, which is a hormone that helps regulate blood sugar levels. By regulating insulin sensitivity in these cells, MIR4746 may be able to contribute to the development of insulin resistance and the development of type 2 diabetes.

Overall, MIR4746 is a protein that is involved in several important cellular processes and has been shown to play a role in the development and progression of several neurological and metabolic disorders. Its potential as a drug target makes it an attractive target for the development of new treatments for these conditions. Further research is needed to fully understand the role of MIR4746 in these processes and to develop safe and effective drugs that target this protein.

Protein Name: MicroRNA 4746

The "MIR4746 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4746 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506